Skip to content

Author

Zhibing Ming

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer

Simple Summary Doxorubicin is an important chemotherapy drug for breast cancer, but treatment resistance and limited antitumor immune responses can reduce its effectiveness. In this study, we investigated HSP90AA1, a stress-related molecular chaperone that may help breast cancer cells adapt to chemotherapy. Using publi...

Rui Chen, Yao Jin, Chang-Bin Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.